Dalbavancin Use for the Treatment of Methicillin-resistant Staphylococcus aureus Pneumonia

Dalbavancin is a lipoglycopeptide with a long half-life that allows infrequent dosing. It is indicated for the treatment of acute bacterial skin and skin structure infections caused by susceptible organisms, including Staphylococcus aureus and methicillin-resistant S. aureus (MRSA). Although this ag...

Descripción completa

Detalles Bibliográficos
Autores principales: Barber, Katie E., Tirmizi, Amir, Finley, Richard, Stover, Kayla R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497404/
https://www.ncbi.nlm.nih.gov/pubmed/28706403
http://dx.doi.org/10.4103/jpp.JPP_2_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497404/
https://www.ncbi.nlm.nih.gov/pubmed/28706403
http://dx.doi.org/10.4103/jpp.JPP_2_17

Ejemplares similares